Sakura Finetek, a global leader in histopathology products and Evident Scientific, a wholly owned subsidiary of Olympus Corporation, and a global leader in microscopy and imaging solutions, today ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Pramana, Inc., an AI-enabled health-tech company modernizing the pathology sector, launched its Digital Pathology as a Service (DPaaS) solution for creating digital ...
Hospitalization Risk During Chemotherapy for Advanced Cancer: Development and Validation of Risk Stratification Models Using Real-World Data Digital pathology (DP), referring to the digitization of ...
Pramana's digital pathology solution equips Intermountain Health with superior, consistent digital images, enhancing the efficiency of clinical research and streamlining workflows CAMBRIDGE, ...
Digital pathology is increasingly recognized as the future of diagnostic and research workflows, providing greater clarity and deeper insights than traditional microscope-based approaches. Looking ...
The ongoing digitisation of pathology is a transformative change that offers new opportunities to increase efficiency, especially in cancer care, where over 90% of all tumors are confirmed by ...
A team of Dana-Farber researchers has identified a potential new way to assess clinically valuable features of clear cell renal cell carcinoma (ccRCC), a form of kidney cancer, using image processing ...
A team of Dana-Farber researchers has identified a potential new way to assess clinically valuable features of clear cell renal cell carcinoma (ccRCC), a form of kidney cancer, using image processing ...
Hospitalization Risk During Chemotherapy for Advanced Cancer: Development and Validation of Risk Stratification Models Using Real-World Data Digital pathology (DP), referring to the digitization of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results